These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1356778)

  • 1. Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertension.
    Man in 't Veld AJ
    Eur Heart J; 1992 Jun; 13 Suppl A():58-60. PubMed ID: 1356778
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension.
    Genovesi-Ebert A; Marabotti C; Palombo C; Ghione S; Cattaneo G; Noseda A; Spinazzi A
    Eur Heart J; 1992 Jun; 13 Suppl A():45-8. PubMed ID: 1356776
    [No Abstract]   [Full Text] [Related]  

  • 3. Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
    Sheiban I; Arosio E; Tonni S; Montresor G; Priante F; Lechi A
    Eur Heart J; 1992 Jun; 13 Suppl A():37-44. PubMed ID: 1356775
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus.
    Fariello R; Boni E; Corda L; Zaninelli A; Noseda A; Spinazzi A
    Eur Heart J; 1992 Jun; 13 Suppl A():65-9. PubMed ID: 1356779
    [No Abstract]   [Full Text] [Related]  

  • 5. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
    Warren JB; Dollery CT
    J Hypertens Suppl; 1988 Dec; 6(2):S43-9. PubMed ID: 2906700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
    van Zwieten PA
    Fortschr Med; 1992 Jun; 110(17):330-2. PubMed ID: 1353745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Drugs; 1990; 40 Suppl 4():1-8; discussion 28-30. PubMed ID: 1982649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-receptor blocking agents and centrally acting antihypertensive agents].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 1988 Apr; 132(14):611-4. PubMed ID: 2896303
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
    Doyle AE
    J Hypertens Suppl; 1988 Dec; 6(2):S51-3. PubMed ID: 2906701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha Adrenergic Blockers in the Treatment of Hypertension--A Nephrologist's Perspective.
    Taraphder A
    J Assoc Physicians India; 2014 Sep; 62(9 Suppl):30-3. PubMed ID: 26245040
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protective effect of alpha beta-blockers on hypertensive target-organ damage].
    Kai H; Imaizumi T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():587-90. PubMed ID: 15171441
    [No Abstract]   [Full Text] [Related]  

  • 16. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.
    Jain KS; Bariwal JB; Kathiravan MK; Phoujdar MS; Sahne RS; Chauhan BS; Shah AK; Yadav MR
    Bioorg Med Chem; 2008 May; 16(9):4759-800. PubMed ID: 18378462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic bases of antihypertensive drugs with mechanisms of multi-factor action].
    Van Zwieten PA
    Therapie; 1990; 45 Suppl 2():177-82. PubMed ID: 1971122
    [No Abstract]   [Full Text] [Related]  

  • 19. The case for alpha 1-adrenoceptor antagonists as first-line antihypertensive agents.
    Elliott HL
    J Hum Hypertens; 1991 Aug; 5(4):309-11. PubMed ID: 1683405
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug treatment of hypertension in the elderly: the role of alpha-adrenoceptor blockade.
    Man In't Veld AJ; van der Camme TJ; van Loon K
    Br J Urol; 1998 Mar; 81 Suppl 1():21-5; discussion 64-6. PubMed ID: 9589013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.